Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up of a Multicentre, Randomized, Double-blind, Placebo-controlled Trial (AN004T) Assessing the Efficacy and Tolerability of 2 Dosing Regimens of AllerT in Adult Subjects Allergic to Birch Pollen

NCT02143583 is registered in ClinicalTrials.gov with Anergis as lead sponsor.

NCT NCT02143583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02143583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up of a Multicentre, Randomized, Double-blind, Placebo-controlled Trial (AN004T) Assessing the Efficacy and Tolerability of 2 Dosing Regimens of AllerT in Adult Subjects Allergic to Birch Pollen
Lead sponsor
Anergis
Phase
Observational
Overall status
Completed
Start date
February 28, 2014
Completion date
July 31, 2014
Enrollment
196 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

birch pollen allergy